Evidence map›Paper›PMID 40575570›Full record

ArticleFrontiers in medicine2025

Dual locking plate fixation, PRP-augmented autologous bone grafting, and bioactive core construction for femoral fracture nonunion: a retrospective study of 52 cases.

Zhihao Peng, Shiheng Wang, Ke Jie, Yonghong Dai, Kunyu Wang, Jiahua Wu, Feng Wu, Jianrong Chen

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhihao Peng *The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Shiheng Wang *The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Ke JieThe Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Yonghong DaiThe Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Kunyu WangHenan University of Chinese Medicine, Zhengzhou, China.
Jiahua WuThe Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Feng WuThe Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.
Jianrong ChenThe Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Femoral nonunion remains a challenging orthopedic condition. This study evaluates a combined protocol integrating biomechanical stabilization (dual locking plate fixation) and maximal biological stimulation (PRP-augmented autologous bone grafting with bioactive core construction) to optimize bone healing. Methods: A retrospective analysis included 52 femoral nonunion patients treated at a tertiary trauma center (2020-2024). Outcomes assessed radiographic union (9-month and final follow-up), clinical union time, thigh incision healing, pain scores (VAS), lower extremity function (LEFS), and complications. Results: Cohort demographics: 35 males, 17 females; mean age 41.38 years, BMI 24.79 kg/m Conclusion: The protocol demonstrated efficacy and safety, achieving rapid union (6.56 months), robust functional recovery (LEFS 63.92), and a low incidence of serious complications (3.85%). Biomechanical-biological integration represents a viable strategy for femoral nonunion management.

Indexed as

autologous iliac bone graftingdual plate fixationfemoral fracture nonunionfracture nonunionplatelet-rich plasma

Identifiers

PMID40575570
PMCPMC12198182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.